{"abstract": "Pfizer announced a 15 percent drop in earnings, and again pressed its suit for its rival, AstraZeneca.", "web_url": "https://www.nytimes.com/2014/05/06/business/pfizer-profit-tumbles-15.html", "snippet": "Pfizer announced a 15 percent drop in earnings, and again pressed its suit for its rival, AstraZeneca.", "lead_paragraph": "As the drug maker Pfizer announced a 15 percent drop in first-quarter earnings on Monday, its chief executive renewed his call for its British rival AstraZeneca to accept Pfizer\u2019s offer to buy it.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/06/business/Pfizer/Pfizer-articleLarge.jpg", "height": 835, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/05/06/business/Pfizer/Pfizer-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 835}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/06/business/Pfizer/Pfizer-jumbo.jpg", "height": 1024, "width": 736, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/06/business/Pfizer/Pfizer-superJumbo.jpg", "height": 1038, "width": 746, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/06/business/Pfizer/Pfizer-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/05/06/business/Pfizer/Pfizer-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/06/business/Pfizer/Pfizer-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Profit Off, Pfizer Again Aims to Lure AstraZeneca", "kicker": null, "content_kicker": null, "print_headline": "Profits Off, Pfizer Again Aims to Lure AstraZeneca", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Thomas, Katie", "rank": 1, "major": "N"}, {"name": "subject", "value": "Company Reports", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": 4, "major": "N"}], "pub_date": "2014-05-05T12:57:18+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/264730d6-adaf-541f-8ab9-019d00864527", "word_count": 592, "uri": "nyt://article/264730d6-adaf-541f-8ab9-019d00864527"}